We handle 100% of your medical device cybersecurity requirements, from penetration testing and SPDF development to SBOMs, threat modeling, and eSTAR submission-ready documentation.
250+ Submissions. Zero Rejections.
30 minutes | No Cost | No Commitment
ISO 14971 • FDA Guidance • UL 2900 • AAMI TIR57 • NIST 800-115 • IEC 62304 • ISO 13485 • AAMI TIR97 • ISO 27001 • IEC 81001-5-1 • IEC 62443-4-1 • ANSI/AAMI SW96
Medical device cybersecurity keeps a device safe and effective when exposed to real-world misuse, malicious activity, and software supply chain risk. It is not generic IT security. It focuses on how the device actually operates across hospital networks, patient homes, companion apps, cloud services, and third-party software.
The stakes are real and measurable. Most MedTech teams are scrambling to keep up with evolving FDA requirements — and the cost of a misstep is not just a delay.
A cybersecurity deficiency letter can push your product launch back 3–6 months. For a $30M/year device, that's real revenue lost — plus remediation costs on top.
Incomplete or inconsistent documentation is the most common reason for FDA cybersecurity deficiency letters. One gap in traceability can unravel an otherwise strong submission.
Cybersecurity vulnerabilities in cleared devices can trigger recalls, coordinated disclosure events, and lasting reputational damage — all avoidable with the right postmarket infrastructure.
The FDA's current premarket cybersecurity guidance was issued February 3, 2026, addressing Section 524B "cyber devices." Reviewers focus on three things:
A clear chain from realistic threats to security controls and test evidence.
Data flows, trust boundaries, and dependencies that reflect actual use.
Plans to monitor, receive, and respond to vulnerabilities after launch.
We speak the language so your team doesn't have to learn it from scratch. Every framework, standard, and guidance document relevant to your submission is addressed in our work.
Mandatory cybersecurity requirements for cyber devices in 510(k), De Novo, and PMA submissions.
FDA's current guidance on cybersecurity in medical device premarket submissions, issued February 3, 2026.
FDA's required electronic submission format. We deliver eSTAR-ready cybersecurity documentation.
End-to-end secure development lifecycle aligned with FDA premarket expectations.
Security risk management methodology FDA reviewers expect to see referenced.
Consensus standard for medical device cybersecurity risk management.
International standard for security activities in the health software product lifecycle.
Foundational risk management standard, integrated with cybersecurity risk under TIR57.
Software lifecycle requirements that intersect with secure development practices.
You’re building breakthrough medical technology to improve lives. But with FDA requirements, evolving cyber threats, and tight timelines, cybersecurity can feel overwhelming—and high-stakes.
At Blue Goat Cyber, we make it simple.
We specialize in full-service cybersecurity for medical devices — so you can protect your patients, meet regulatory demands, and bring your device to market with confidence.
Design Consulting: Build cybersecurity into your device from day one
Penetration Testing: Simulate real-world threats before they reach patients
SPDF, SBOMs, & Risk Documentation: 100% FDA-ready and aligned with AAMI TIR57, ISO 14971, IEC 62304
FDA Deficiency Support: Fix issues fast, with experts who’ve done it hundreds of times
Continuous Compliance Management: Patching, monitoring, reporting — done for you
Legacy Device Protection: Secure existing devices without breaking functionality
Thoroughly enjoyed working with Blue Goat Cyber! Very knowledgeable and professional. Would work with again without hesitation!
Cybersecurity shouldn’t derail your launch. Blue Goat helps you proactively address FDA expectations and product security risk so you can stay on schedule and stay credible.
We handle all the cybersecurity requirements for your medical device’s premarket submission, including thorough documentation, testing, and regulatory compliance.
We handle all third-party vulnerability assessments and penetration testing requirements for your medical device's FDA and EU MDR submissions, ensuring full compliance with both regulatory standards.
We specialize in delivering comprehensive postmarket cybersecurity support for medical device manufacturers, ensuring ongoing compliance with FDA and EU MDR requirements while maintaining device security and effectiveness throughout its lifecycle.
We protect patients by helping medical device teams build secure products and back it up with clear, submission-ready cybersecurity evidence.
A future where connected medical devices are secure by design, trusted in clinical environments, and resilient over time.
We deliver medical device cybersecurity services that reduce review friction, strengthen real-world security, and support FDA expectations across the product lifecycle.